Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis.

ABSTRACT:

SUBMITTER: Dimopoulos MA 

PROVIDER: S-EPMC10084376 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature